In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)

The in vitro activity of ceftazidime in combination with NXL104 versus 470 Pseudomonas aeruginosa clinical isolates was evaluated using Clinical and Laboratory Standards Institute (CLSI) broth microdilution methods. Ceftazidime had MIC(90)s of 8 μg/ml and 32 μg/ml in the presence and absence of NXL1...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Walkty, A., DeCorby, M., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2011
Assuntos:
Susceptibility
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101411/
https://ncbi.nlm.nih.gov/pubmed/21422208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01696-10
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares